Warning: Invalid argument supplied for foreach() in /home/dheesqdo/public_html/wp-content/plugins/smart-blocks/inc/generate-css.php on line 252
Warning: Invalid argument supplied for foreach() in /home/dheesqdo/public_html/wp-content/plugins/smart-blocks/inc/generate-css.php on line 46
Boqortooyada Midowday (UK) waxay noqotay waddankii ugu horreeyay adduunka ee oggolaaday kaniiniga ka hortagga fayraska ee COVID-19 ooy si wadajir ah u soo saareen Merck iyo Ridgeback Biotherapeutics.
Hay’adda Nidaaminta Dawooyinka iyo Daryeelka Caafimaadka (MHRA) ayaa ku talisay Khamiista in dawada, molnupiravir, loo isticmaalo sida ugu dhakhsaha badan ee suurtogalka ah ka dib baaritaanka lagu ogaaday Waxtarka kaniinkaasi u leeyahay COVID-19
Tani waa daawaynta ka hortagga fayraska ee ugu horreysa ee COVID-19 ee la oggolaado, taasoo calaamad u ah la dagaallanka masiibada, iyadoo iftiinka cagaaran uu imanayo ka hor fasax sharciyeedka suurtagalka ah
La taliyayaasha Mareykanka ayaa kulmi doona bishaan si ay ugu codeeyaan in molnupiravir la ogolaado iyo in kale.
Daawaynta lagula tacaalayo masiibada, oo dishay in ka badan 5.2 milyan oo qof adduunka oo dhan, ayaa ilaa hadda inta badan diiradda lagu saaray tallaallada. Ikhtiyaarada kale, oo ay ku jiraan remdesivir ka-hortagga fayraska ee Gilecaad iyo steroid-ka guud ee dexamethasone, ayaa guud ahaan la bixiyaa ka dib marka bukaan la dhigo.
Merck’s molnupiravir si dhow ayaa loo daawaday tan iyo markii xogta bishii hore muujisay inay kala badh ka dhimi karto fursadaha ay u dhintaan ama isbitaal la dhigo kuwa aadka ugu nugul inay ku dhacaan COVID-19 daran marka hore loo siiyo kaniinkan.
Daawada, oo lagu sumadeeyo Lagevrio gudaha Boqortooyada Midowday, waxaa loogu talagalay in lagu soo bandhigo khaladaadka code-ka hiddaha ee fayraska sababa COVID-19 waxaana la qaataa laba jeer maalintii shan maalmood.
Molnupiravir waxa kale oo lagu bartaa tijaabo wakhti dambe ah oo lagaga hortagayo caabuqa.
Isku xigxiga fayraska ee la sameeyay ilaa hadda waxay muujisay inay waxtar u leedahay dhammaan noocyada kala duwan ee coronavirus, Merck wuxuu yidhi, oo ay ku jiraan nooca Delta ee aadka u faafa.
Dawladda Boqortooyada Midowday (UK) iyo Adeegga Caafimaadka Qaranka (NHS) ayaa xaqiijin doona sida daawaynta loogu diri doono bukaannada “xilligeeda”.Bishii hore, mas’uuliyiintu waxay heshiis la galeen Merck si loo xaqiijiyo 480,000 oo koorsooyinka molnupiravir ah.
“Waxaan si xawli ah uga shaqeyneynaa guud ahaan dowladda iyo NHS-ta si aan u dejino qorshooyin aan ku geyno molnupiravir bukaannada iyada oo loo marayo daraasad qaran sida ugu dhaqsaha badan,” Xoghayaha Caafimaadka Sajid Javid ayaa ku yiri hadal uu soo dhigay Twitter-ka Khamiistii.
Oggolaanshaha degdega ah ee Boqortooyada Midowday ayaa timid iyadoo dowladdu ay la halgameyso sidii ay u xakameyn lahayd caabuqyada sii kordhaya.
Wadanku wuxuu leeyahay ilaa 40,000 kiis maalinle ah oo COVID-19 ah, marka loo eego celceliska todobada maalmood ee ugu dambeeyay. Wadarta guud ayaa ah ka labaad kaliya qiyaastii 74,000 ee Maraykanka maalintii, oo ay ku nool yihiin shan jeer in ka badan.
Xogta la sii daayay habeenimadii Arbacada ayaa muujisay faafitaanka COVID-19 ee England uu gaaray heerkii ugu sarreeyay ee rikoorka bishii hore, oo ay hogaaminayaan tiro badan oo kiisas ah oo caruur ah iyo qalliin ka dhacay koonfur-galbeed ee dalka.
Cadaadis ayaa ku sii kordhaya dowladda si ay u fuliso “Qorshaha B” ee looga golleeyahay in laga ilaaliyo NHS-ta dalabaadka aan sii jiri karin, ee ku lug leh waajibaadka maaskaro, gudbinta tallaalka iyo amarada guriga-ka-soo baxa.
XIGASHO: REUTERS
